secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvectis Pharma, Inc. (NVCT)
CIK:        0001875558
Form:       8-K
Filed at:   2026-06-30T20:43:15+00:00
Accession:  0001104659-26-079360
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvectis Pharma prices $100M public offering of 5M shares at $20.00 per share
-----------------------------------------------------------------------------

- Priced underwritten public offering of 5,000,000 shares at $20.00 per share for gross proceeds of $100 million.
- Net proceeds expected ~$93 million (or ~$107 million if underwriters' 30-day option for 750,000 additional shares is exercised).
- Offering expected to close on July 1, 2026; Cantor Fitzgerald acting as sole book-runner.
- Proceeds to fund development of NXP100, NXP200, NXP900 and for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/0001104659-26-079360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/tm2619346d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-079360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer